Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Gains from Investment Securities (2018 - 2026)

Organogenesis Holdings has reported Gains from Investment Securities over the past 8 years, most recently at $1.2 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 133.39% year-over-year to $1.2 million; the TTM value through Dec 2025 reached -$2.0 million, up 76.22%, while the annual FY2025 figure was $12.0 million, 13.26% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $1.2 million at Organogenesis Holdings, down from $11.9 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $53.1 million in Q4 2021 and troughed at -$5.2 million in Q4 2022.
  • A 5-year average of $4.7 million and a median of $1.4 million in 2022 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: soared 13032.67% in 2021 and later plummeted 1809.17% in 2024.
  • Year by year, Gains from Investment Securities stood at $53.1 million in 2021, then plummeted by 109.75% to -$5.2 million in 2022, then skyrocketed by 104.21% to $218000.0 in 2023, then plummeted by 1809.17% to -$3.7 million in 2024, then soared by 133.39% to $1.2 million in 2025.
  • Business Quant data shows Gains from Investment Securities for ORGO at $1.2 million in Q4 2025, $11.9 million in Q3 2025, and $1.6 million in Q2 2025.